HepaVue
Hepavue has developed the world’s first proprietary virtual liver biopsy, transforming liver disease diagnosis by making it affordable, painless, and safe. Their technology combines molecular tracers and AI-based medical imaging to provide accurate early detection of progressive liver diseases, replacing traditional invasive biopsies. This innovative approach aims to drastically reduce the prevalence of terminal liver diseases, ultimately saving millions of lives and ensuring tailored care through personalized assessment of therapeutic responses. With a focus on timely and proactive care, Hepavue is positioned to lead a significant change in liver health management.
HepaVue
Hepavue has developed the world’s first proprietary virtual liver biopsy, transforming liver disease diagnosis by making it affordable, painless, and safe. Their technology combines molecular tracers and AI-based medical imaging to provide accurate early detection of progressive liver diseases, replacing traditional invasive biopsies. This innovative approach aims to drastically reduce the prevalence of terminal liver diseases, ultimately saving millions of lives and ensuring tailored care through personalized assessment of therapeutic responses. With a focus on timely and proactive care, Hepavue is positioned to lead a significant change in liver health management.